Universe Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|
Revenue | $12,884 | $13,841 | $18,467 |
Gross Profit | 3,244 | 4,063 | 6,014 |
EBITDA | -12,050 | -3,806 | 591 |
EBIT | -12,299 | -4,057 | 333 |
Net Income | -13,101 | -5,447 | -715 |
Net Change In Cash | 12,884 | 13,841 | 18,467 |
Free Cash Flow | -2,497 | -3,683 | 4,798 |
Cash | 8,861 | 5,285 | 12,954 |
Basic Shares | 3,645 | 3,625 | 3,624 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $32,308 | $40,143 | $47,982 | $30,703 |
Gross Profit | 10,315 | 21,891 | 25,326 | 14,093 |
EBITDA | -3,215 | -7,326 | 14,196 | 10,612 |
EBIT | -3,723 | -7,860 | 13,749 | 10,202 |
Net Income | -6,163 | -8,736 | 11,319 | 7,558 |
Net Change In Cash | 32,308 | 40,143 | 47,982 | 30,703 |
Free Cash Flow | 1,075 | -1,406 | -15,587 | 6,063 |
Cash | 5,285 | 5,711 | 8,077 | 10,058 |
Basic Shares | 3,625 | 3,625 | 3,625 | 3,675 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-12-31 | -$0.48 |
2022-06-30 | $0.08 |
2021-12-31 | $0.60 |
2021-06-30 | $0.44 |
